Home › Funds › Sofinnova Investments, Inc. › RAPP

Sofinnova Investments, Inc. position in RAPP

RAPPORT THERAPEUTICS INC · Health Care

Sofinnova Investments, Inc. reported holding 1,904,408 shares of RAPP (RAPPORT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$79.4M, representing 4.23% of its reported portfolio and ranking #5 among its reported holdings. Sofinnova Investments, Inc. has disclosed RAPP holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)1.90M sh
Reported value held$79.36M
Portfolio Weight4.23%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s RAPP position evolved

Sofinnova Investments, Inc. first disclosed a stake in RAPP in Q2 2024 at 1,951,562 shares (US$45.4M). The position peaked in Q2 2026 at 1,904,408 shares, worth US$79.4M. Across 9 filings, Sofinnova Investments, Inc. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,904,408 shares valued at US$79.4M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 1.95M $45.39M New
Q3 2024 2.00M $40.87M Add
Q4 2024 2.00M $35.40M Hold
Q1 2025 2.00M $20.02M Hold
Q2 2025 2.00M $22.69M Hold
Q3 2025 1.95M $57.84M Reduce
Q4 2025 1.90M $57.78M Reduce
Q1 2026 1.90M $59.59M Hold
Q2 2026 1.90M $79.36M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RAPP and 13F data

RAPP (RAPPORT THERAPEUTICS INC) is a Health Care company. 66 other funds we track also report a position in RAPP — the largest reported positions include TRV GP V, LLC (US$261.7M), ARCH Venture Management, LLC (US$155.4M), Cormorant Asset Management, LP (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RAPP

All RAPP fund holders →

FAQ

How long has Sofinnova Investments, Inc. held RAPP?

Sofinnova Investments, Inc. has disclosed RAPP holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Sofinnova Investments, Inc.'s current position in RAPP?

As of Q2 2026, Sofinnova Investments, Inc. holds 1.90M shares of RAPP (RAPPORT THERAPEUTICS INC), valued at $79.36M, representing 4.23% of its reported portfolio and ranking #5.

Has Sofinnova Investments, Inc. been buying or selling RAPP?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. held unchanged its position in RAPP. The position peaked in Q2 2026 at 1.90M shares.

Which other funds hold RAPP?

Other major institutional holders of RAPP include TRV GP V, LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.